Short Interest in Precipio, Inc. (NASDAQ:PRPO) Declines By 15.6%

Precipio, Inc. (NASDAQ:PRPO) was the target of a significant drop in short interest in the month of December. As of December 31st, there was short interest totalling 2,700 shares, a drop of 15.6% from the December 15th total of 3,200 shares. Based on an average daily trading volume, of 7,100 shares, the short-interest ratio is presently 0.4 days. Approximately 0.2% of the company’s stock are short sold.

Precipio Stock Up 5.9 %

Precipio stock traded up $0.36 during trading hours on Friday, hitting $6.51. 10,823 shares of the stock traded hands, compared to its average volume of 7,864. Precipio has a one year low of $4.31 and a one year high of $7.30. The company has a market cap of $9.63 million, a PE ratio of -3.56 and a beta of 1.41. The firm’s 50-day moving average price is $5.86 and its two-hundred day moving average price is $5.94. The company has a current ratio of 0.73, a quick ratio of 0.60 and a debt-to-equity ratio of 0.02.

About Precipio

Precipio, Inc, a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels.